@misc{indiciaec86e9ace2c9e,
  title = {Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years.},
  author = {Tomas Olsson and Xavier Montalban and Reinhard Hohlfeld and Carlo Pozzilli and Mark S Freedman and Till Sprenger and Robert J Fox and Eva Kubala Havrdova and Fred Lublin and Nandini Raghavan and Janice Wong and Andrea Vaclavkova and Magdalena Pirozek-Lawniczek and Amita Singh and Michel Burcklen and Ludwig Kappos},
  year = {2026},
  doi = {10.1016/j.msard.2026.107403},
  url = {https://pubmed.ncbi.nlm.nih.gov/42561748/},
  note = {Source identifier: 42561748}
}